Literature DB >> 25239843

Anxiety of patients undergoing CT imaging-an underestimated problem?

Christoph M Heyer1, Johannes Thüring2, Stefan P Lemburg2, Nina Kreddig3, Monika Hasenbring3, Martha Dohna4, Volkmar Nicolas2.   

Abstract

RATIONALE AND
OBJECTIVES: Prospective evaluation of anxiety in patients undergoing computed tomography (CT) imaging using a standardized state-trait anxiety inventory (STAI-S) and identification of possible risk factors.
MATERIAL AND METHODS: During a 9-month interval, patients undergoing CT were questioned using STAI-S. Additionally, 10 questions concerning specific procedure-related features (claustrophobia, radiation, administration of contrast, and so forth) were added. Moreover, sex, age, admitting subspecialty, organ region, reason for imaging, and prior imaging studies were recorded. Statistical analysis was performed using the Student t test and linear regression analysis; significance level was set to 5%.
RESULTS: Of 6122 patients, 825 patients undergoing CT (14%) were included (67% men; average age, 54 ± 17 years). Average STAI was 42 ± 10 with women (45 ± 11 vs. 41 ± 10; P < .001) and patients who received intravenous contrast (43 ± 10 vs. 42 ± 11; P = .021) showing significantly higher anxiety levels compared to those without contrast. Patients with investigations of their extremities (41 ± 11 vs. 43 ± 10; P = .020) and trauma patients (41 ± 11 vs. 43 ± 10; P = .006) revealed significantly lower STAI results. Patients who had never received a CT scan before showed significantly greater STAI-S values than those with repeat studies (42 ± 10 vs. 41 ± 11; P = .036). Females had greater fears concerning examination results (P < .001), radiation exposure (P = .032), administration of contrast (P = .014), and claustrophobia (P < .001). Patients with known malignancies had a significantly higher level of anxiety concerning their CT results (P = .002).
CONCLUSIONS: Anxiety does not only occur before MRI but also occur before CT. Its sources are manifold and include communication of CT results, administration of contrast agents, radiation exposure, and claustrophobia. In this setting, women seemed to be more receptive than men.
Copyright © 2015 AUR. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Computed tomography; anxiety; contrast agent; radiation exposure

Mesh:

Year:  2014        PMID: 25239843     DOI: 10.1016/j.acra.2014.07.014

Source DB:  PubMed          Journal:  Acad Radiol        ISSN: 1076-6332            Impact factor:   3.173


  6 in total

Review 1.  General anaesthesia for patients with a history of a contrast medium-induced anaphylaxis: a useful prophylaxis?

Authors:  Ingrid Boehm; Knud Nairz; John Morelli; Patricia Silva Hasembank Keller; Johannes Thomas Heverhagen
Journal:  Br J Radiol       Date:  2017-09-06       Impact factor: 3.039

2.  Effect of patient anxiety on image motion artefacts in CBCT.

Authors:  Elif Yıldızer Keriş
Journal:  BMC Oral Health       Date:  2017-04-04       Impact factor: 2.757

3.  Medical Imaging Outpatients' Experiences With Receiving Information Required for Informed Consent and Preparation: A Cross-Sectional Study.

Authors:  Lisa L Hyde; Lisa J Mackenzie; Allison W Boyes; Michael Symonds; Sandy Brown; Rob Sanson-Fisher
Journal:  J Patient Exp       Date:  2018-04-18

4.  Perceived patient burden and acceptability of whole body MRI for staging lung and colorectal cancer; comparison with standard staging investigations.

Authors:  Ruth Ec Evans; Stuart A Taylor; Sandra Beare; Steve Halligan; Alison Morton; Alf Oliver; Andrea Rockall; Anne Miles
Journal:  Br J Radiol       Date:  2018-03-20       Impact factor: 3.039

Review 5.  Anxiety at outpatient hysteroscopy.

Authors:  Pietro Gambadauro; Ramesan Navaratnarajah; Vladimir Carli
Journal:  Gynecol Surg       Date:  2015-05-13

6.  Use of video-based multimedia information to reduce anxiety before office hysteroscopy.

Authors:  Aysu Akca; Gulseren Yilmaz; Aytul Corbacioglu Esmer; Semra Yuksel; Nadiye Koroglu; Berna Aslan Cetin
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2019-10-28       Impact factor: 1.195

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.